354 related articles for article (PubMed ID: 18660726)
1. Cognitive adverse effects of chemotherapy in breast cancer patients.
Correa DD; Ahles TA
Curr Opin Support Palliat Care; 2007 Apr; 1(1):57-62. PubMed ID: 18660726
[TBL] [Abstract][Full Text] [Related]
2. Neurocognitive changes in cancer survivors.
Correa DD; Ahles TA
Cancer J; 2008; 14(6):396-400. PubMed ID: 19060604
[TBL] [Abstract][Full Text] [Related]
3. The nature and severity of cognitive impairment associated with adjuvant chemotherapy in women with breast cancer: a meta-analysis of the current literature.
Falleti MG; Sanfilippo A; Maruff P; Weih L; Phillips KA
Brain Cogn; 2005 Oct; 59(1):60-70. PubMed ID: 15975700
[TBL] [Abstract][Full Text] [Related]
4. The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: results of a prospective, randomized, longitudinal trial.
Wefel JS; Lenzi R; Theriault RL; Davis RN; Meyers CA
Cancer; 2004 Jun; 100(11):2292-9. PubMed ID: 15160331
[TBL] [Abstract][Full Text] [Related]
5. Preliminary results of a longitudinal study of changes in cognitive function in breast cancer patients undergoing chemotherapy with doxorubicin and cyclophosphamide.
Jansen CE; Dodd MJ; Miaskowski CA; Dowling GA; Kramer J
Psychooncology; 2008 Dec; 17(12):1189-95. PubMed ID: 18506671
[TBL] [Abstract][Full Text] [Related]
6. The influence of priming and pre-existing knowledge of chemotherapy-associated cognitive complaints on the reporting of such complaints in breast cancer patients.
Schagen SB; Das E; van Dam FS
Psychooncology; 2009 Jun; 18(6):674-8. PubMed ID: 19021129
[TBL] [Abstract][Full Text] [Related]
7. Neurocognitive effects of chemotherapy and endocrine therapies in the treatment of breast cancer: recent perspectives.
Walker CH; Drew BA; Antoon JW; Kalueff AV; Beckman BS
Cancer Invest; 2012 Feb; 30(2):135-48. PubMed ID: 22250588
[TBL] [Abstract][Full Text] [Related]
8. Cognitive impairment associated with chemotherapy for cancer: report of a workshop.
Tannock IF; Ahles TA; Ganz PA; Van Dam FS
J Clin Oncol; 2004 Jun; 22(11):2233-9. PubMed ID: 15169812
[TBL] [Abstract][Full Text] [Related]
9. Cognitive impairments associated with breast cancer treatments: results from a longitudinal study.
Quesnel C; Savard J; Ivers H
Breast Cancer Res Treat; 2009 Jul; 116(1):113-23. PubMed ID: 18629633
[TBL] [Abstract][Full Text] [Related]
10. Cognitive side-effects of adjuvant treatments.
Burstein HJ
Breast; 2007 Dec; 16 Suppl 2():S166-8. PubMed ID: 17719225
[TBL] [Abstract][Full Text] [Related]
11. A meta-analysis of the sensitivity of various neuropsychological tests used to detect chemotherapy-induced cognitive impairment in patients with breast cancer.
Jansen CE; Miaskowski CA; Dodd MJ; Dowling GA
Oncol Nurs Forum; 2007 Sep; 34(5):997-1005. PubMed ID: 17878128
[TBL] [Abstract][Full Text] [Related]
12. [Cognitive impairments and breast cancer: a critical review of the literature].
Vandenbossche S; Fery P; Razavi D
Bull Cancer; 2009 Feb; 96(2):239-48. PubMed ID: 19258230
[TBL] [Abstract][Full Text] [Related]
13. Acupuncture for chemotherapy-associated cognitive dysfunction: a hypothesis-generating literature review to inform clinical advice.
Johnston MF; Yang C; Hui KK; Xiao B; Li XS; Rusiewicz A
Integr Cancer Ther; 2007 Mar; 6(1):36-41. PubMed ID: 17351025
[TBL] [Abstract][Full Text] [Related]
14. Chemotherapy, neurotoxicity, and cognitive changes in breast cancer.
Dutta V
J Cancer Res Ther; 2011; 7(3):264-9. PubMed ID: 22044805
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of cognitive function associated with chemotherapy: a review of published studies and recommendations for future research.
Vardy J; Rourke S; Tannock IF
J Clin Oncol; 2007 Jun; 25(17):2455-63. PubMed ID: 17485710
[TBL] [Abstract][Full Text] [Related]
16. Short-term effects of treatment-induced hormonal changes on cognitive function in breast cancer patients: results of a multicenter, prospective, longitudinal study.
Hermelink K; Henschel V; Untch M; Bauerfeind I; Lux MP; Munzel K
Cancer; 2008 Nov; 113(9):2431-9. PubMed ID: 18823033
[TBL] [Abstract][Full Text] [Related]
17. Cognitive function, fatigue, and menopausal symptoms in breast cancer patients receiving adjuvant chemotherapy: evaluation with patient interview after formal assessment.
Downie FP; Mar Fan HG; Houédé-Tchen N; Yi Q; Tannock IF
Psychooncology; 2006 Oct; 15(10):921-30. PubMed ID: 16477674
[TBL] [Abstract][Full Text] [Related]
18. Cognitive functions in long-term survivors of ovarian cancer.
Correa DD; Zhou Q; Thaler HT; Maziarz M; Hurley K; Hensley ML
Gynecol Oncol; 2010 Nov; 119(2):366-9. PubMed ID: 20630576
[TBL] [Abstract][Full Text] [Related]
19. Cognitive dysfunction following adjuvant chemotherapy for breast cancer: two case studies.
Paraska K; Bender CM
Oncol Nurs Forum; 2003; 30(3):473-8. PubMed ID: 12719746
[TBL] [Abstract][Full Text] [Related]
20. The cognitive effects of adjuvant chemotherapy in early stage breast cancer: a prospective study.
Stewart A; Collins B; Mackenzie J; Tomiak E; Verma S; Bielajew C
Psychooncology; 2008 Feb; 17(2):122-30. PubMed ID: 17518411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
